Delivery Order SPE2DB22D1106-SPE2DB25FDTG6

Award Date 1/6/25
Potential Completion Date 1/7/25
Potential Value $1.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of 4,567,016,240 units of Methimazole 10 mg tablets. The firm-fixed-price delivery order contract, valued at $1,178.78, has an ultimate completion date of January 24, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4,564,531,006 units of the pharmaceutical product methimazole 5 mg tablets. The fixed-price, firm-fixed delivery order contract, valued at $1,816.00, was issued by the Defense Logistics Agency (DLA) Troop Support Medical on May 7, 2024 and has an ultimate completion date of May 8, 2024. The contract does not have a set-aside designation. Amerisourcebergen, a major pharmaceutical...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor in the United States. The contract, valued at $6,540.37, is for the delivery of Methimazole 10 mg tablets. This delivery order contract has a firm-fixed price pricing type and an ultimate completion date of September 24, 2024. The contract was awarded on September 23, 2024 and does not have a set-aside designation. Amerisourcebergen...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed price of $1,385.67 and an ultimate completion date of December 5, 2022. It covers the procurement of 4,559,255,829 units of the medication Methimazole 5 mg tablets in 90-count packages. This award is not associated with a set-aside program. AmerisourceBergen, a for-profit...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $2,958.65 firm fixed-price delivery order is for the supply of Methimazole 5 mg tablets, a medication used to treat hyperthyroidism. The award does not have a set-aside designation and is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025,...
This federal contract award, valued at $1,551.17, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is a delivery order for the supply of 4,566,135,029 units of Methimazole 5 mg tablets, with an ultimate completion date of October 18, 2024. The contract type is Firm Fixed Price, and the pricing is Firm Fixed Price. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a...
This federal contract award is for the delivery of Methimazole 10 mg Tablets to the Defense Logistics Agency (DLA) Troop Support Medical. The contract was awarded to the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The award, valued at $1,729.69, is a Firm Fixed Price Delivery Order with a completion date of February 8, 2023. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $2,007.36 and is for the supply of Methimazole 10 mg tablets in quantities of 100s. The contract is a Firm Fixed Price type and has an ultimate completion date of January 8, 2025. This contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The award is for the supply of methimazole 5 mg tablets for $2,185.98. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA valued up to $999,999,999.00 through December 2025. This IDC serves as the primary contract vehicle for...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,590.30 firm fixed-price contract is for the delivery of Methimazole 10 mg tablets, a medication used to treat hyperthyroidism. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which provides a comprehensive range of...
  • SPE2DB22D1106
    Indefinite Delivery Contract
  • SPE2DB22D1106-SPE2DB25FDTG6
    Delivery Order

This federal contract award, with the ID SPE2DB22D1106|SPE2DB25FDTG6, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,797.48, is a delivery order for the supply of 4,566,848,124 tablets of the drug Methimazole 5 mg. The contract is a firm fixed-price arrangement with a completion date of January 7, 2025.

Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 4/13/25, 12:42 AM